← Leaderboards
Sapna Syngal
Dana-Farber Cancer Inst
$13,605,208
Attributed
$16,015,608
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,015,608 · 9
By mechanism
R01$8,470,285 · 3
U01$4,820,800 · 1
K24$1,746,386 · 1
K07$657,971 · 1
P30$320,166 · 3
Top collaborators
- Robert S Bresalier3 shared
- Luigi Ricciardiello1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Shuji Ogino$10,631,973
- Timothy R Rebbeck$50,819,475
- Gordon J Harris$11,607,211
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsRisk AssessmentGeneticResearch PersonnelMutationBaseGenesCancer RiskInheritedGene MutationClinicColorectal CancerMismatch RepairSyndromeHigh RiskHereditary Nonpolyposis Colorectal NeoplasmsClinical TrialsPerformanceFundingEvaluationProgramsValidationLeadDana-Farber Cancer Institute
Grant awards (46)
Great Lakes New England Clinical Validation Center$2,033,845
U01 · FY2025 · CA
Design of a Scalable and Sustainable PREMMplus Patient-Facing App and Implementation in Three Healthcare Settings$689,204
R01 · FY2025 · CA · contact PI
Program 60: Cancer Risk, Prevention, and Early Detection$46,974
P30 · FY2025 · CA · contact PI
Great Lakes New England Clinical Validation Center$966,077
U01 · FY2024 · CA
Inclusion of Diverse and Medically Underserved Populations in the Design and Implementation of the PREMMplus Patient-Facing App$766,773
R01 · FY2024 · CA · contact PI
Program 60: Cancer Risk, Prevention, and Early Detection$40,758
P30 · FY2024 · CA · contact PI
Great Lakes New England Clinical Validation Center$1,016,923
U01 · FY2023 · CA
Program 60: Cancer Risk, Prevention, and Early Detection$42,116
P30 · FY2023 · CA · contact PI
Great Lakes New England Clinical Validation Center$803,955
U01 · FY2022 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment$446,335
R01 · FY2022 · CA · contact PI
Program 60: Cancer Risk, Prevention, and Early Detection$42,116
P30 · FY2022 · CA · contact PI
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment$455,443
R01 · FY2021 · CA · contact PI
Program 13: Cancer Risk and Disparities$72,530
P30 · FY2021 · CA · contact PI
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment$455,443
R01 · FY2020 · CA · contact PI
Program 13: Cancer Risk and Disparities$72,724
P30 · FY2020 · CA · contact PI
Program 13: Cancer Risk and Disparities$2,948
P30 · FY2020 · CA · contact PI
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment$441,779
R01 · FY2019 · CA · contact PI
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment$455,443
R01 · FY2018 · CA · contact PI
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer$449,215
R01 · FY2016 · CA · contact PI
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer$447,386
R01 · FY2015 · CA · contact PI
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer$412,026
R01 · FY2014 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$196,620
K24 · FY2014 · CA · contact PI
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer$424,662
R01 · FY2013 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$196,841
K24 · FY2013 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$197,010
K24 · FY2012 · CA · contact PI
Validation and extension of the PREMM Model for mismatch repair gene mutations$379,100
R01 · FY2011 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$196,416
K24 · FY2011 · CA · contact PI
Validation and extension of the PREMM Model for mismatch repair gene mutations$402,586
R01 · FY2010 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$197,209
K24 · FY2010 · CA · contact PI
Validation and extension of the PREMM Model for mismatch repair gene mutations$396,689
R01 · FY2009 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$152,458
K24 · FY2009 · CA · contact PI
Validation and extension of the PREMM Model for mismatch repair gene mutations$414,226
R01 · FY2008 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$152,458
K24 · FY2008 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$152,458
K24 · FY2007 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$152,458
K24 · FY2006 · CA · contact PI
The Genetics and Prevention of Gastrointestinal Cancers$152,458
K24 · FY2005 · CA
CANCER SCREENING COMPLIANCE IN HEREDITARY COLON CANCER$46,704
K07 · FY2005 · CA
INHERITED MSH6 MUTATIONS IN DIVERSE COLORECTAL CANCERS$388,238
R01 · FY2004 · CA
CANCER SCREENING COMPLIANCE IN HEREDITARY COLON CANCER$135,837
K07 · FY2004 · CA
INHERITED MSH6 MUTATIONS IN DIVERSE COLORECTAL CANCERS$378,379
R01 · FY2003 · CA
CANCER SCREENING COMPLIANCE IN HEREDITARY COLON CANCER$135,837
K07 · FY2003 · CA
INHERITED MSH6 MUTATIONS IN DIVERSE COLORECTAL CANCERS$352,764
R01 · FY2002 · CA
CANCER SCREENING COMPLIANCE IN HEREDITARY COLON CANCER$67,919
K07 · FY2002 · CA
INHERITED MSH6 MUTATIONS IN DIVERSE COLORECTAL CANCERS$314,594
R01 · FY2001 · CA
CANCER SCREENING COMPLIANCE IN HEREDITARY COLON CANCER$135,837
K07 · FY2001 · CA
CANCER SCREENING COMPLIANCE IN HEREDITARY COLON CANCER$135,837
K07 · FY2000 · CA